• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>IGI

IGI

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. S&P Reaffirms Its ‘A-’ Financial Strength and Counterparty Credit Ratings for IGI Bermuda and ‘A-’ Financial Strength Rating for IGI UK

    S&P Reaffirms Its ‘A-’ Financial Strength and Counterparty Credit Ratings for IGI Bermuda and ‘A-’ Financial Strength Rating for IGI UK

  2. Chugai and Galderma Announce Global License Agreement for Nemolizumab (CIM331), Novel Biologic for Skin Diseases

    Chugai and Galderma Announce Global License Agreement for Nemolizumab (CIM331), Novel Biologic for Skin Diseases

  3. UPDATE: Pound's Brexit-driven slump sets U.K. companies up for an M&A wave

    UPDATE: Pound's Brexit-driven slump sets U.K. companies up for an M&A wave

  4. UPDATE: Pound's Brexit-driven slump sets U.K. companies up for an M&A wave

    UPDATE: Pound's Brexit-driven slump sets U.K. companies up for an M&A wave

  5. UPDATE: Pound jumps above $1.32 ahead of key BOE decision

    UPDATE: Pound jumps above $1.32 ahead of key BOE decision

  6. CURRENCIES: Pound Jumps Above $1.32 Ahead Of Key BOE Decision

    CURRENCIES: Pound Jumps Above $1.32 Ahead Of Key BOE Decision

  7. Australia Stocks Rise for Fifth Straight Session

    Australia Stocks Rise for Fifth Straight Session

  8. UPDATE: 3 reasons why you shouldn't buy into the S&P 500's breakout effort

    UPDATE: 3 reasons why you shouldn't buy into the S&P 500's breakout effort

  9. Asian Shares Mostly Up on Positive U.S. Data

    Asian Shares Mostly Up on Positive U.S. Data

  10. ASIA MARKETS: Asian Markets Mostly Gain On U.S. Data Cheer

    ASIA MARKETS: Asian Markets Mostly Gain On U.S. Data Cheer

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.